Clinical Roundup SWOG study: Patients with metastatic prostate cancer living significantly longer May 06, 2022Vol.48 No.18
Funding Opportunities DoD Prostate Cancer Research Program anticipated funding opportunities for FY22 April 15, 2022Vol.48 No.15
Drugs & Targets FDA approves Pluvicto for metastatic castration-resistant prostate cancer March 25, 2022Vol.48 No.12
In Brief Arul Chinnaiyan awarded Sjöberg Prize for prostate cancer research February 18, 2022Vol.48 No.07
Clinical Roundup Interim findings from MIRAGE phase III randomized trial support MRIdian MRI guidance in SBRT for localized prostate cancer February 18, 2022Vol.48 No.07
Clinical Roundup Yale study finds rates of PSA testing for prostate cancer increased after revised national guidelines November 19, 2021Vol.47 No.43
FreeTrials & Tribulations No longer “experimental”—Prostate cancer patients should have access to proton therapy November 05, 2021Vol.47 No.41By Shaakir Hasan
FreeTrials & Tribulations Precision oncology must evolve to address health disparities June 04, 2021Vol.47 No.22By Brandon Mahal and Jeffrey Venstrom
FreeSatireTrials & Tribulations The imaginary interview(with apologies to Molière, aka Jean-Baptiste Poquelin) May 11, 2018Vol.44 No.19By Derek Raghavan
Pfizer, Astellas report positive results from trial of Xtandi in non-metastatic castration-resistant disease November 07, 2017Vol.40 No.09
